Affiliated Managers Group, Goldman Sachs and Vaxcyte among analyst rating and price target changes
AMG•Analysts revised ratings and price targets for several U.S.-listed companies. Jefferies raised Affiliated Managers Group’s target to $456 from $441 and cut Goldman Sachs’ to $1,124 from $1,299; Needham raised Vaxcyte’s to $122 from $110.
1. Analyst changes
The roundup included rating and price-target revisions for dozens of U.S.-listed companies. Jefferies raised Affiliated Managers Group’s price target to $456 from $441 and cut Goldman Sachs’ target to $1,124 from $1,299, while Needham raised Vaxcyte’s target to $122 from $110.
2. Other notable revisions
JP Morgan raised Regeneron Pharmaceuticals’ target to $950 from $900 and Charles Schwab’s to $131 from $126. Berenberg cut Nike to sell from hold and lowered its price target to $27.50 from $49.
